SG11202113242QA - Isolation of fetal cells using facs - Google Patents
Isolation of fetal cells using facsInfo
- Publication number
- SG11202113242QA SG11202113242QA SG11202113242QA SG11202113242QA SG11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA
- Authority
- SG
- Singapore
- Prior art keywords
- facs
- isolation
- fetal cells
- fetal
- cells
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19179087 | 2019-06-07 | ||
| PCT/EP2020/065832 WO2020245459A1 (en) | 2019-06-07 | 2020-06-08 | Isolation of fetal cells using facs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202113242QA true SG11202113242QA (en) | 2021-12-30 |
Family
ID=66793879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202113242QA SG11202113242QA (en) | 2019-06-07 | 2020-06-08 | Isolation of fetal cells using facs |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11573229B2 (es) |
| EP (2) | EP4242652A3 (es) |
| JP (1) | JP2022536121A (es) |
| KR (1) | KR20220047929A (es) |
| CN (1) | CN114041053A (es) |
| AU (1) | AU2020289708B2 (es) |
| BR (1) | BR112021024474A2 (es) |
| CA (1) | CA3142663A1 (es) |
| EA (1) | EA202193200A1 (es) |
| ES (1) | ES2955791T3 (es) |
| IL (2) | IL288621B2 (es) |
| MX (1) | MX2021015044A (es) |
| PL (1) | PL3980773T3 (es) |
| SG (1) | SG11202113242QA (es) |
| UA (1) | UA128273C2 (es) |
| WO (1) | WO2020245459A1 (es) |
| ZA (1) | ZA202110215B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4242652A3 (en) | 2019-06-07 | 2023-12-06 | Arcedi Biotech ApS | Isolation of fetal cells using facs |
| CN113087793B (zh) * | 2021-05-12 | 2022-04-12 | 福州迈新生物技术开发有限公司 | 抗ck14蛋白单克隆抗体及其细胞株、制备方法和应用 |
| CN112980779B (zh) * | 2021-05-20 | 2021-08-24 | 广州凯普医药科技有限公司 | 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法 |
| EP4445135A1 (en) * | 2021-12-06 | 2024-10-16 | Arcedi Biotech ApS | Isolation and diagnostics of fetal cells |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641628A (en) | 1989-11-13 | 1997-06-24 | Children's Medical Center Corporation | Non-invasive method for isolation and detection of fetal DNA |
| US5629147A (en) | 1992-07-17 | 1997-05-13 | Aprogenex, Inc. | Enriching and identifying fetal cells in maternal blood for in situ hybridization |
| JPH08511205A (ja) | 1993-04-02 | 1996-11-26 | ジェオ リサーチ エス．アー．エール．エル． | 低温流体の噴射による切断設備と方法 |
| WO1995003431A1 (en) | 1993-07-19 | 1995-02-02 | Aprogenex, Inc. | Enriching and identifying fetal cells in maternal blood for in situ hybridization |
| US5714325A (en) | 1993-09-24 | 1998-02-03 | New England Medical Center Hospitals | Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
| US5648222A (en) | 1994-07-27 | 1997-07-15 | The Trustees Of Columbia University In The City Of New York | Method for preserving cells, and uses of said method |
| GB9603249D0 (en) | 1996-02-16 | 1996-04-17 | Univ Nottingham | Foetal cell analysis |
| GB0009179D0 (en) | 2000-04-13 | 2000-05-31 | Imp College Innovations Ltd | Non-invasive prenatal diagnosis |
| EP1302533A4 (en) | 2000-05-16 | 2004-11-17 | Kyowa Hakko Kogyo Kk | NEW METHOD FOR INDUCING DIFFERENTIATION OF EMBRYONIC STEM CELLS IN EECTODERMAL CELLS AND THEIR USE |
| AU2002306768A1 (en) | 2001-03-20 | 2002-10-03 | Ortho-Clinical Diagnostics, Inc. | Expression profiles and methods of use |
| US20030036100A1 (en) | 2001-04-10 | 2003-02-20 | Imperial College Innovations Ltd. | Simultaneous determination of phenotype and genotype |
| FR2824144B1 (fr) | 2001-04-30 | 2004-09-17 | Metagenex S A R L | Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel |
| EP1572087B1 (en) | 2002-03-08 | 2008-05-14 | PDL BioPharma, Inc. | Antibodies against cancer antigen tmeff2 and uses thereof |
| US20050181429A1 (en) | 2003-04-03 | 2005-08-18 | Monaliza Medical Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
| US20040197832A1 (en) | 2003-04-03 | 2004-10-07 | Mor Research Applications Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
| TWI367260B (en) | 2005-03-18 | 2012-07-01 | Univ Hong Kong Chinese | Method for detecting the presence of a fetus with trisomy 21 in a pregnant woman and kit thereof |
| WO2006119569A1 (en) | 2005-05-11 | 2006-11-16 | Genetic Technologies Limtied | Methods of enriching fetal cells |
| DE602006017878D1 (de) | 2005-12-08 | 2010-12-09 | Fcmb Aps | Nachweis fötaler zellen aus mütterlichem blut |
| GB0616045D0 (en) | 2006-08-11 | 2006-09-20 | Univ Bristol | Blood cell separation |
| ES2564312T3 (es) | 2007-05-01 | 2016-03-21 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Métodos y kits para detectar células fetales en la sangre materna |
| EP2250497B1 (en) | 2008-02-18 | 2014-09-10 | Genetic Technologies Limited | Cell processing and/or enrichment methods |
| PT2385992E (pt) | 2009-01-07 | 2015-04-16 | Arcedi Biotech Aps | Enriquecimento e identificação de células fetais em sangue materno e ligandos para esse uso |
| RU2011147219A (ru) | 2009-04-22 | 2013-05-27 | Клиникал Джиномикс Пти. Лтд. | Способ и устройство для изолирования искомой биочастицы из биологического образца |
| HUE034937T2 (en) | 2010-11-09 | 2018-03-28 | Arcedi Biotech Aps | Enrichment and detection of fetal cells from maternal blood and ligands for this purpose |
| EP4008270A1 (en) | 2012-06-22 | 2022-06-08 | Preprogen LLC | Method for obtaining fetal cells and fetal cellular components |
| EP3489691A1 (en) | 2014-05-15 | 2019-05-29 | Kellbenx Inc. | Preparation of fetal nucleated red blood cells (nrbcs) for diagnostic testing |
| EP4242652A3 (en) | 2019-06-07 | 2023-12-06 | Arcedi Biotech ApS | Isolation of fetal cells using facs |
-
2020
- 2020-06-08 EP EP23183492.0A patent/EP4242652A3/en active Pending
- 2020-06-08 EP EP20730073.2A patent/EP3980773B1/en active Active
- 2020-06-08 MX MX2021015044A patent/MX2021015044A/es unknown
- 2020-06-08 IL IL288621A patent/IL288621B2/en unknown
- 2020-06-08 CN CN202080041987.5A patent/CN114041053A/zh active Pending
- 2020-06-08 EA EA202193200A patent/EA202193200A1/ru unknown
- 2020-06-08 UA UAA202107627A patent/UA128273C2/uk unknown
- 2020-06-08 BR BR112021024474A patent/BR112021024474A2/pt unknown
- 2020-06-08 CA CA3142663A patent/CA3142663A1/en active Pending
- 2020-06-08 PL PL20730073.2T patent/PL3980773T3/pl unknown
- 2020-06-08 IL IL308999A patent/IL308999A/en unknown
- 2020-06-08 JP JP2021572557A patent/JP2022536121A/ja active Pending
- 2020-06-08 ES ES20730073T patent/ES2955791T3/es active Active
- 2020-06-08 AU AU2020289708A patent/AU2020289708B2/en active Active
- 2020-06-08 KR KR1020217042790A patent/KR20220047929A/ko unknown
- 2020-06-08 WO PCT/EP2020/065832 patent/WO2020245459A1/en unknown
- 2020-06-08 SG SG11202113242QA patent/SG11202113242QA/en unknown
-
2021
- 2021-02-23 US US17/182,749 patent/US11573229B2/en active Active
- 2021-12-09 ZA ZA2021/10215A patent/ZA202110215B/en unknown
-
2022
- 2022-10-26 US US17/973,938 patent/US20230130312A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021015044A (es) | 2022-04-06 |
| IL288621B2 (en) | 2024-05-01 |
| CN114041053A (zh) | 2022-02-11 |
| IL288621B1 (en) | 2024-01-01 |
| KR20220047929A (ko) | 2022-04-19 |
| CA3142663A1 (en) | 2020-12-10 |
| UA128273C2 (uk) | 2024-05-22 |
| EA202193200A1 (ru) | 2022-03-17 |
| ES2955791T3 (es) | 2023-12-07 |
| WO2020245459A1 (en) | 2020-12-10 |
| EP3980773B1 (en) | 2023-07-12 |
| AU2020289708A1 (en) | 2022-01-20 |
| US20210199664A1 (en) | 2021-07-01 |
| AU2020289708B2 (en) | 2024-07-25 |
| PL3980773T3 (pl) | 2023-11-27 |
| EP3980773A1 (en) | 2022-04-13 |
| JP2022536121A (ja) | 2022-08-12 |
| BR112021024474A2 (pt) | 2022-01-18 |
| EP4242652A3 (en) | 2023-12-06 |
| IL288621A (en) | 2022-02-01 |
| US11573229B2 (en) | 2023-02-07 |
| US20230130312A1 (en) | 2023-04-27 |
| ZA202110215B (en) | 2023-06-28 |
| IL308999A (en) | 2024-01-01 |
| EP4242652A2 (en) | 2023-09-13 |
| EP3980773C0 (en) | 2023-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202110215B (en) | Isolation of fetal cells using facs | |
| IL287553B1 (en) | Modified pluripotent cells | |
| EP3350313A4 (en) | DERIVATION OF HEPATIC ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | |
| IL276131A (en) | Methods for using car t cells | |
| IL286218A (en) | Solid state forms of ripretinib | |
| EP4040552A4 (en) | SECONDARY CELL | |
| EP3449018A4 (en) | REAL-TIME PCR WITH MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA) FOR THE EVALUATION OF FETAL WELL-BEING | |
| EP3768823A4 (en) | METHODS OF USING ISLET CELLS | |
| IL285422A (en) | Transposon-based modifications of immune cells | |
| GB201904612D0 (en) | Reaction of glycoladehyde | |
| EP3941631A4 (en) | ISOLATION OF SINGLE CELLS AND THEIR USES | |
| ZA202105808B (en) | Secure storage isolation | |
| SI3749673T1 (sl) | Kristalinična oblika biktegravir natrija | |
| EP3242554A4 (en) | Concise synthesis of urea derivatives of amphotericin b | |
| GB2572914B (en) | In vitro propagation of primary cancer cells | |
| HUE061671T2 (hu) | Akkumulátorcella | |
| IL288301A (en) | Methods for the culture of pluripotent stem cells | |
| EP3755213C0 (en) | USES OF FETAL TISSUE EXTRACT | |
| CA211336S (en) | Set of sofa modules | |
| ZA202006925B (en) | Hopper coupler | |
| GB201917499D0 (en) | Methods of synthesis | |
| EP3801573A4 (en) | METHODS OF ACTIVATING CELLS VIA PTP-1B INHIBITION | |
| SG11202110459RA (en) | Phase-correction of radiofrequency-multiplexed signals | |
| GB2581953B (en) | Synchronisation signals | |
| AU2018900373A0 (en) | Pre-natal cell isolation |